{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:41:59Z","timestamp":1787654519979,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005825","name":"National Institute of Food and Agriculture","doi-asserted-by":"publisher","award":["TENX-2011-0255"],"award-info":[{"award-number":["TENX-2011-0255"]}],"id":[{"id":"10.13039\/100005825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000199","name":"U.S. Department of Agriculture","doi-asserted-by":"publisher","award":["2022-38821-37352"],"award-info":[{"award-number":["2022-38821-37352"]}],"id":[{"id":"10.13039\/100000199","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.biopha.2024.117221","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T03:32:56Z","timestamp":1722915176000},"page":"117221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Combining luteolin and curcumin synergistically suppresses triple-negative breast cancer by regulating IFN and TGF-\u03b2 signaling pathways"],"prefix":"10.1016","volume":"178","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9667-2316","authenticated-orcid":false,"given":"Xiaoyong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.117221_bib1","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2024.117221_bib2","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41576-019-0114-6","article-title":"Resolving genetic heterogeneity in cancer","volume":"20","author":"Turajlic","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.biopha.2024.117221_bib3","doi-asserted-by":"crossref","first-page":"9413","DOI":"10.1021\/acs.jmedchem.6b01026","article-title":"Polyphenolic phytochemicals in cancer prevention and therapy: bioavailability versus bioefficacy","volume":"60","author":"Estrela","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.117221_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.maturitas.2016.08.004","article-title":"Cancer chemoprevention by dietary phytochemicals: epidemiological evidence","volume":"94","author":"Baena Ruiz","year":"2016","journal-title":"Maturitas"},{"key":"10.1016\/j.biopha.2024.117221_bib5","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nrc1189","article-title":"Cancer chemoprevention with dietary phytochemicals","volume":"3","author":"Surh","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2024.117221_bib6","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1002\/ptr.6480","article-title":"Potential of phytochemicals in breast cancer prevention and therapy","volume":"33","author":"Pagano","year":"2019","journal-title":"Phytother. Res"},{"key":"10.1016\/j.biopha.2024.117221_bib7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2174\/1568009615666141229152256","article-title":"Phytochemicals for breast cancer therapy: current status and future implications","volume":"15","author":"Siddiqui","year":"2015","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.biopha.2024.117221_bib8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.semcancer.2015.11.001","article-title":"Resveratrol for breast cancer prevention and therapy: preclinical evidence and molecular mechanisms","volume":"40-41","author":"Sinha","year":"2016","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.biopha.2024.117221_bib9","article-title":"Combined luteolin and indole-3-carbinol synergistically constrains ERalpha-positive breast cancer by dual inhibiting estrogen receptor alpha and cyclin-dependent kinase 4\/6 pathway in cultured cells and xenograft mice","volume":"13","author":"Wang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2024.117221_bib10","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2024.117221_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1987588","article-title":"Paving luteolin therapeutic potentialities and agro-food-pharma applications: emphasis on in vivo pharmacological effects and bioavailability traits","volume":"2021","author":"Taheri","year":"2021","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.biopha.2024.117221_bib12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4143\/crt.2014.46.1.2","article-title":"Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice","volume":"46","author":"Prasad","year":"2014","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.biopha.2024.117221_bib13","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41573-018-0011-2","article-title":"Interferons alpha and beta in cancer: therapeutic opportunities from new insights","volume":"18","author":"Borden","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2024.117221_bib14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-021-00566-3","article-title":"Interferon-gamma: teammate or opponent in the tumour microenvironment?","volume":"22","author":"Gocher","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2024.117221_bib15","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/bjc.2012.201","article-title":"The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression","volume":"106","author":"Houthuijzen","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2024.117221_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrc3447","article-title":"G. Regulatory networks defining EMT during cancer initiation and progression","volume":"13","author":"Craene","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2024.117221_bib17","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nrc3984","article-title":"MYC: connecting selective transcriptional control to global RNA production","volume":"15","author":"Kress","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2024.117221_bib18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrc1590","article-title":"Tumour stem cells and drug resistance","volume":"5","author":"Dean","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2024.117221_bib19","first-page":"599","article-title":"Curcumin and cancer stem cells: curcumin has asymmetrical effects on cancer and normal stem cells","volume":"35","author":"Sordillo","year":"2015","journal-title":"Anticancer Res."},{"key":"10.1016\/j.biopha.2024.117221_bib20","doi-asserted-by":"crossref","first-page":"134","DOI":"10.18632\/genesandcancer.194","article-title":"Increased Smad3 and reduced Smad2 levels mediate the functional switch of TGF-beta from growth suppressor to growth and metastasis promoter through TMEPAI\/PMEPA1 in triple negative breast cancer.","volume":"10","author":"Singha","year":"2019","journal-title":"Genes Cancer"},{"key":"10.1016\/j.biopha.2024.117221_bib21","first-page":"153","article-title":"The effects of turmeric (curcumin) on tumor suppressor protein (p53) and estrogen receptor (ERalpha) in breast cancer cells","volume":"9","author":"Hallman","year":"2017","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"10.1016\/j.biopha.2024.117221_bib22","doi-asserted-by":"crossref","first-page":"76622","DOI":"10.18632\/oncotarget.20635","article-title":"Estrogen receptor beta2 induces proliferation and invasiveness of triple negative breast cancer cells: association with regulation of PHD3 and HIF-1alpha","volume":"8","author":"Bialesova","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.biopha.2024.117221_bib23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jsbmb.2012.08.007","article-title":"Androgen receptor in triple negative breast cancer","volume":"133","author":"McNamara","year":"2013","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.biopha.2024.117221_bib24","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10549-011-1715-8","article-title":"Androgen receptor expression in primary breast cancer and its predictive and prognostic value in patients treated with neoadjuvant chemotherapy","volume":"130","author":"Loibl","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.biopha.2024.117221_bib25","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0014-5793(98)01304-0","article-title":"Intestinal absorption of luteolin and luteolin 7-O-beta-glucoside in rats and humans","volume":"438","author":"Shimoi","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2024.117221_bib26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1146\/annurev-food-032818-121738","article-title":"Curcumin: recent advances in the development of strategies to improve oral bioavailability","volume":"10","author":"Sanidad","year":"2019","journal-title":"Annu. Rev. Food Sci. Technol."},{"key":"10.1016\/j.biopha.2024.117221_bib27","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1248\/bpb.b14-00780","article-title":"Luteolin attenuates doxorubicin-induced cytotoxicity to MCF-7 human breast cancer cells","volume":"38","author":"Sato","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.biopha.2024.117221_bib28","first-page":"27","article-title":"Inhibitory effect of luteolin on the proliferation of human breast cancer cell lines induced by epidermal growth factor","volume":"68","author":"Sui","year":"2016","journal-title":"Sheng Li Xue Bao"},{"key":"10.1016\/j.biopha.2024.117221_bib29","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/aps.2011.97","article-title":"Curcumin enhanced antiproliferative effect of mitomycin C in human breast cancer MCF-7 cells in vitro and in vivo","volume":"32","author":"Zhou","year":"2011","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.biopha.2024.117221_bib30","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.2147\/OTT.S313961","article-title":"The anti-cancer effect of four curcumin analogues on human glioma cells","volume":"14","author":"Luo","year":"2021","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.biopha.2024.117221_bib31","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1089\/jmf.2016.0115","article-title":"Antiadipogenic effects and mechanisms of combinations of genistein, epigallocatechin-3-gallate, and\/or resveratrol in preadipocytes","volume":"20","author":"Ahmed","year":"2017","journal-title":"J. Med. Food"},{"key":"10.1016\/j.biopha.2024.117221_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2022.109083","article-title":"Synergistic anti-inflammatory effects and mechanisms of the combination of resveratrol and curcumin in human vascular endothelial cells and rodent aorta","volume":"108","author":"Zhang","year":"2022","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.biopha.2024.117221_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14123001","article-title":"Combined curcumin and luteolin synergistically inhibit colon cancer associated with Notch1 and TGF-beta signaling pathways in cultured cells and xenograft mice","volume":"14","author":"Aromokeye","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biopha.2024.117221_bib34","first-page":"759","article-title":"Synergistic anti-colon cancer effects and mechanisms by combined phytochemicals","volume":"28","author":"Aromokeye","year":"2021","journal-title":"Cancer Cell Res."},{"key":"10.1016\/j.biopha.2024.117221_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2019.108222","article-title":"Combination of curcumin and luteolin synergistically inhibits TNF-alpha-induced vascular inflammation in human vascular cells and mice","volume":"73","author":"Zhang","year":"2019","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.biopha.2024.117221_bib36","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1124\/mol.106.032185","article-title":"A critical role of luteolin-induced reactive oxygen species in blockage of tumor necrosis factor-activated nuclear factor-kappaB pathway and sensitization of apoptosis in lung cancer cells","volume":"71","author":"Ju","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2024.117221_bib37","article-title":"The inhibitory activity of curcumin on P-glycoprotein and its uptake by and efflux from LS180 cells is not affected by its galenic formulation","volume":"10","author":"Flory","year":"2021","journal-title":"Antioxid. (Basel)"},{"key":"10.1016\/j.biopha.2024.117221_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108800","article-title":"Chemoresistance mechanisms of breast cancer and their countermeasures","volume":"114","author":"Ji","year":"2019","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2024.117221_bib39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jnutbio.2019.03.009","article-title":"Synergistic anti-inflammatory effects and mechanisms of combined phytochemicals","volume":"69","author":"Zhang","year":"2019","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.biopha.2024.117221_bib40","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1055\/s-2006-957450","article-title":"Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers","volume":"64","author":"Shoba","year":"1998","journal-title":"Planta Med."},{"key":"10.1016\/j.biopha.2024.117221_bib41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41523-023-00508-3","article-title":"Immunotherapy in breast cancer: an overview of current strategies and perspectives","volume":"9","author":"Debien","year":"2023","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.biopha.2024.117221_bib42","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/cr.2016.149","article-title":"Innate immune signaling and regulation in cancer immunotherapy","volume":"27","author":"Corrales","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.biopha.2024.117221_bib43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/bjc.2015.398","article-title":"Activation of IFN\/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer","volume":"114","author":"Legrier","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2024.117221_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2020.100773","article-title":"Epithelial-mesenchymal transition in cancer: a historical overview","volume":"13","author":"Ribatti","year":"2020","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.biopha.2024.117221_bib45","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022145","article-title":"TGF-beta family signaling in the control of cell proliferation and survival","volume":"9","author":"Zhang","year":"2017","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.biopha.2024.117221_bib46","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1158\/1078-0432.CCR-12-0977","article-title":"c-Myc and cancer metabolism","volume":"18","author":"Miller","year":"2012","journal-title":"Clin. Cancer Res."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224011053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224011053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:29:53Z","timestamp":1777861793000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224011053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":46,"alternative-id":["S0753332224011053"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117221","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combining luteolin and curcumin synergistically suppresses triple-negative breast cancer by regulating IFN and TGF-\u03b2 signaling pathways","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.117221","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117221"}}